BCS Wealth Management’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$231K Buy
3,556
+7
+0.2% +$488 0.04% 251
2026
Q2
$238K Buy
3,549
+289
+9% +$21.1K 0.04% 252
2026
Q1
$249K Sell
3,260
-3,296
-50% -$238K 0.05% 226
2025
Q4
$419K Buy
+6,556
New +$404K 0.04% 245
2023
Q2
– Sell
-2,615
Closed -$221K – 126
2023
Q1
$221K Sell
2,615
-490
-16% -$42.1K 0.1% 146
2022
Q4
$253K Hold
3,105
– – 0.11% 160
2022
Q3
$221K Sell
3,105
-65
-2% -$5.84K 0.1% 166
2022
Q2
$285K Buy
3,170
+65
+2% +$6.73K 0.13% 138
2022
Q1
$348K Buy
+3,105
New +$364K 0.14% 135
2021
Q3
– Sell
-2,050
Closed -$239K – 174
2021
Q2
$239K Hold
2,050
– – 0.13% 139
2021
Q1
$226K Hold
2,050
– – 0.11% 143
2020
Q4
$206K Buy
+2,050
New +$190K 0.11% 139

Other funds holding EMN

BCS Wealth Management's EMN Position: Q3 2026 in Review

BCS Wealth Management increased its Eastman Chemical (EMN) stake by 0.2% in Q3 2026, buying an estimated $488 and bringing the position to 3,556 shares worth $231K. The position accounts for 0.04% of the portfolio, ranked #251.

BCS Wealth Management first reported a position in EMN in Q4 2020 and has held it in 12 quarters since. The position peaked at $419K in Q4 2025. 421 funds tracked by Wall St. Rank hold EMN as of Q3 2026.

  • BCS Wealth Management held 3,556 shares of Eastman Chemical worth $231K as of Q3 2026.
  • BCS Wealth Management bought 7 Eastman Chemical shares in Q3 2026, an estimated $488.
  • Eastman Chemical made up 0.04% of BCS Wealth Management's portfolio in Q3 2026, its #251 holding.
  • BCS Wealth Management first reported a position in Eastman Chemical in Q4 2020 and has held it in 12 quarters since.
  • BCS Wealth Management's Eastman Chemical position peaked at $419K in Q4 2025.
  • 421 funds tracked by Wall St. Rank held Eastman Chemical as of Q3 2026.

Based on BCS Wealth Management's 13F filing for Q3 2026, filed 3 Nov 2026.